Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03279250
What this trial is testing

Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 86
Not applicableStudy completedNCT01118078
What this trial is testing

Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor

Who this might be right for
Clear Cell Sarcoma of the KidneyRecurrent Wilms Tumor and Other Childhood Kidney TumorsRhabdoid Tumor of the Kidney+5 more
Children's Oncology Group 185
Testing effectiveness (Phase 2)Active Not RecruitingNCT06183489
What this trial is testing

Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
European Myeloma Network B.V. 50
Not applicableStudy completedNCT00624260
What this trial is testing

Impact of PET Scan on the Curative Strategy of Colo-rectal Cancers : A Randomized Study

Who this might be right for
Colorectal Cancer
Assistance Publique - Hôpitaux de Paris 240
Testing effectiveness (Phase 2)Study completedNCT00186420
What this trial is testing

Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation

Who this might be right for
Prostate Cancer
Stanford University 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06599827
What this trial is testing

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC

Who this might be right for
Rectal Cancer
Shanghai Zhongshan Hospital 54
Not applicableStudy completedNCT01816841
What this trial is testing

Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care

Who this might be right for
Lip and Oral Cavity Squamous Cell CarcinomaOral Cavity Verrucous CarcinomaStage 0 Lip and Oral Cavity Cancer+1 more
Ohio State University Comprehensive Cancer Center 68
Early research (Phase 1)Study completedNCT00063973
What this trial is testing

Cilengitide in Treating Children With Refractory Primary Brain Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+23 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT06937866
What this trial is testing

Maintenance Zanzalintinib With Etoposide After HDCT in GCT

Who this might be right for
Germ Cell Tumor
Indiana University 38
Not applicableNot Yet RecruitingNCT07597642
What this trial is testing

ON-treatment Single-cell Analysis for the Identification of Early Tumor Response Biomarkers on Prospective Collected Serial Tumor Biopsies in Triple Negative Breast Cancer Patient During Standard Neoadjuvant Chemo-immunotherapy

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
IRCCS San Raffaele 55
Not applicableUnknownNCT05883683
What this trial is testing

Molecular Study and Precision Medicine for Colorectal Cancer

Who this might be right for
Advanced Colorectal CarcinomaRecurrent Colorectal Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100
Large-scale testing (Phase 3)Study completedNCT03723941
What this trial is testing

Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma

Who this might be right for
Adrenocortical Carcinoma
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 40
Not applicableUnknownNCT04905329
What this trial is testing

Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations

Who this might be right for
Solid TumorHigh-Risk CancerBreast Cancer+3 more
Moscow Clinical Scientific Center 285
Testing effectiveness (Phase 2)Study completedNCT00928902
What this trial is testing

Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma

Who this might be right for
Melanoma
University of Virginia 41
Large-scale testing (Phase 3)Study completedNCT02678351
What this trial is testing

68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery

Who this might be right for
Stage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Andrei Iagaru 74
Early research (Phase 1)Ended earlyNCT03991741
What this trial is testing

Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors

Who this might be right for
Metastatic MelanomaLocally Advanced Refractory/Recurrent MelanomaMetastatic Head and Neck Cancer+1 more
Gregory Daniels 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07303283
What this trial is testing

Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)Locoregionally Advanced Nasopharyngeal CarcinomaAdjuvant Therapy
Kai Hu 140
Testing effectiveness (Phase 2)UnknownNCT03837873
What this trial is testing

DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaTransformed Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 118
Testing effectiveness (Phase 2)WithdrawnNCT06765902
What this trial is testing

Immunotherapy Before and After Surgery

Who this might be right for
High-risk Prostate Cancer
ImmunityBio, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07025369
What this trial is testing

Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial

Who this might be right for
Prostate AdenocarcinomaStage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+1 more
Mayo Clinic 30
Next Page